Heron Therapeutics (HRTX) Total Debt: 2016-2025
Historic Total Debt for Heron Therapeutics (HRTX) over the last 2 years, with Sep 2025 value amounting to $107.5 million.
- Heron Therapeutics' Total Debt rose 332.93% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.5 million, marking a year-over-year increase of 332.93%. This contributed to the annual value of $25.0 million for FY2024, which is 3.14% up from last year.
- Per Heron Therapeutics' latest filing, its Total Debt stood at $107.5 million for Q3 2025, which was up 326.32% from $25.2 million recorded in Q1 2025.
- Heron Therapeutics' 5-year Total Debt high stood at $107.5 million for Q3 2025, and its period low was $24.0 million during Q3 2023.
- Moreover, its 3-year median value for Total Debt was $24.7 million (2024), whereas its average is $35.0 million.
- Data for Heron Therapeutics' Total Debt shows a peak YoY soared of 332.93% (in 2025) over the last 5 years.
- Over the past 3 years, Heron Therapeutics' Total Debt (Quarterly) stood at $24.3 million in 2023, then rose by 3.14% to $25.0 million in 2024, then skyrocketed by 332.93% to $107.5 million in 2025.
- Its Total Debt stands at $107.5 million for Q3 2025, versus $25.2 million for Q1 2025 and $25.0 million for Q4 2024.